Cytotoxicity of Platinum and Palladium Chelates against Osteosarcoma
authors Martins, AS; de Carvalho, ALMB; Lamego, I; Marques, PM; Gil, AM
nationality International
journal CHEMISTRYSELECT
author keywords Cytotoxicity; Metal Chelates; Osteosarcoma; Palladium; Platinum
keywords CISPLATIN RESISTANCE; BIOGENIC POLYAMINES; METAL-COMPLEXES; CELLS; PATHWAY; DRUGS; APOPTOSIS; IMPACT; NMR
abstract This work reports the half maximal inhibitory concentrations, IC50, for conventional anti-cancer drug oxaliplatin (OXA) and potential new drugs Pt(2)Cl(2)Spm (Pt(2)Spm) and Pd(2)Cl(2)Spm (Pd(2)Spm) (Spm=Spermine) against osteosarcoma (OS). IC50 values provided by the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Alamar Blue (AB) viability assays and cell density Sulforhodamine B (SRB) test were compared. Values obtained with MTT and AB were generally in agreement, and a tendency for lower IC50 values was noted by SRB, for OXA and Pd(2)Spm. The relative suitability of different assays is discussed for each chelate. The IC50 trend: cisplatin (cDDP)approximate to Pd(2)Spm
publisher WILEY-V C H VERLAG GMBH
issn 2365-6549
year published 2020
volume 5
issue 20
beginning page 5993
ending page 6000
digital object identifier (doi) 10.1002/slct.202001361
web of science category Chemistry, Multidisciplinary
subject category Chemistry
unique article identifier WOS:000536716700021
  ciceco authors
  impact metrics
journal analysis (jcr 2019):
journal impact factor 1.811
5 year journal impact factor 1.835
category normalized journal impact factor percentile 37.571
dimensions (citation analysis):
altmetrics (social interaction):



 


Apoio

1suponsers_list_ciceco.jpg